Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRANDOLAPRIL | 1MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-10 | 108006 |
| TEVA-TRANDOLAPRIL | 2MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-10 | 108009 |
| TEVA-TRANDOLAPRIL | 4MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-10 | 108012 |
| TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Resolved | 2017-03-13 | 2020-01-21 | 1659 |
| TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION | 0.004% | SOLUTION | Resolved | 2017-03-13 | 2020-01-21 | 1664 |
| TEVA-TRAZODONE | 150MG | TABLET | Resolved | 2020-04-16 | 2020-05-21 | 112385 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2019-10-31 | 2019-11-08 | 97599 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2020-01-30 | 2020-02-13 | 104890 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2018-03-13 | 2018-07-30 | 42576 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2018-03-13 | 2018-07-30 | 42579 |
| TEVA-TRAZODONE | 150MG | TABLET | Resolved | 2021-03-25 | 2021-04-21 | 136335 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2021-05-27 | 2021-08-06 | 140045 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2021-06-03 | 2021-07-15 | 140381 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2021-06-03 | 2021-07-15 | 140384 |
| TEVA-TRAZODONE | 150MG | TABLET | Resolved | 2021-06-10 | 2021-07-15 | 140687 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2021-06-17 | 2021-07-15 | 141116 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2022-05-12 | 2023-07-06 | 160457 |
| TEVA-TRAZODONE | 50MG | TABLET | Resolved | 2022-05-19 | 2023-07-06 | 161009 |
| TEVA-TRAZODONE | 150MG | TABLET | Resolved | 2022-06-16 | 2023-07-06 | 162855 |
| TEVA-TRAZODONE | 100MG | TABLET | Resolved | 2022-06-30 | 2023-06-27 | 163921 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| METHOTREXATE SODIUM INJECTION | 25MG | SOLUTION | Discontinued | 2025-04-25 | 2025-04-25 | 255818 |
| METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 40MG | POWDER FOR SOLUTION | Discontinued | 2021-09-23 | 2021-09-23 | 146061 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-04-11 | 2019-04-11 | 81321 |
| NOVAMOXIN | 500MG | CAPSULE | Discontinued | 2017-06-27 | 2017-06-27 | 14046 |
| NOVAMOXIN | 250MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81316 |
| NOVAMOXIN | 250MG | CAPSULE | Discontinued | 2020-01-24 | 2020-01-24 | 104289 |
| NOVAMOXIN | 25MG | GRANULES FOR SUSPENSION | Discontinued | 2019-04-11 | 2019-04-11 | 81393 |
| NOVAMOXIN | 125MG | TABLET (CHEWABLE) | Discontinued | 2019-10-25 | 2019-10-26 | 97251 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
| NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
| NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
| NOVO-PROFEN | 400MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64920 |
| NOVO-PROFEN | 200MG | TABLET | Discontinued | 2019-04-11 | 2019-04-11 | 81310 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.5G 4G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210194 |
| PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION | 0.375G 3G | POWDER FOR SOLUTION | Discontinued | 2023-11-15 | 2023-11-15 | 210191 |
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 |